Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2018 (2018), Article ID 9749457, 6 pages
https://doi.org/10.1155/2018/9749457
Research Article

Mitochondrial Genome Mutations Associated with Myocardial Infarction

1Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, Moscow 125315, Russia
2Laboratory of Medical Genetics, National Medical Research Center of Cardiology, Moscow 121552, Russia
3Department of Genetics, Southern Federal University, Rostov-on-Don 344006, Russia
4Institute for Atherosclerosis Research, Skolkovo Innovation Center, Moscow 121609, Russia

Correspondence should be addressed to Margarita A. Sazonova; moc.liamg@avonozasaatiragram

Received 22 September 2017; Revised 8 December 2017; Accepted 23 January 2018; Published 18 February 2018

Academic Editor: Zhongjie Shi

Copyright © 2018 Margarita A. Sazonova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. Qi, F. Duan, S. Liu et al., “Effects of bone marrow mononuclear cells delivered through a graft vessel for patients with previous myocardial infarction and chronic heart failure: an echocardiographic study of left ventricular function,” Echocardiography, vol. 32, no. 6, pp. 937–946, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. S. J. White, A. C. Newby, and T. W. Johnson, “Endothelial erosion of plaques as a substrate for coronary thrombosis,” Thrombosis and Haemostasis, vol. 115, no. 3, pp. 509–519, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. X. Zhang, Z. Wang, Z. Wang, M. Fang, and Z. Shu, “The prognostic value of shock index for the outcomes of acute myocardial infarction patients: a systematic review and meta-analysis,” Medicine, vol. 96, no. 38, article e8014, 2017. View at Publisher · View at Google Scholar
  4. J. West and S. Daly, “Predictors of acute myocardial infarction,” American Family Physician, vol. 96, p. 328, 2017. View at Google Scholar
  5. K. J. Smith, A. J. Chadburn, A. Adomaviciene et al., “Coronary spasm and acute myocardial infarction due to a mutation (V734I) in the nucleotide binding domain 1 of ABCC9,” International Journal of Cardiology, vol. 168, no. 4, pp. 3506–3513, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Kallel, M. H. Sbaï, Y. Sédiri et al., “Association between the G20210A polymorphism of prothrombin gene and myocardial infarction in Tunisian population,” Biochemical Genetics, vol. 54, no. 5, pp. 653–664, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. J. C. van Capelleveen, R. S. Kootte, G. K. Hovingh, and A. E. Bochem, “Myocardial infarction in a 36-year-old man with combined ABCA1 and APOA-1 deficiency,” Journal of Clinical Lipidology, vol. 9, no. 3, pp. 396–399, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Lahiri, B. C. Gulman, J. L. Gutierrez, and A. Pefkarou, “Successful conservative treatment of myocardial infarction in a teenager with MTHFR mutation,” IJC Heart & Vasculature, vol. 15, pp. 24-25, 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Hmimech, B. Diakite, H. H. Idrissi et al., “G2691A and C2491T mutations of factor V gene and pre-disposition to myocardial infarction in Morocco,” Biomedical Reports, vol. 5, no. 5, pp. 618–622, 2016. View at Publisher · View at Google Scholar
  10. M. Sazonova, E. Budnikov, Z. Khasanova, I. Sobenin, A. Postnov, and A. Orekhov, “Studies of the human aortic intima by a direct quantitative assay of mutant alleles in the mitochondrial genome,” Atherosclerosis, vol. 2009, no. 204, pp. 184–190, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. A. Sazonova, V. V. Sinyov, V. A. Barinova et al., “Mosaicism of mitochondrial genetic variation in atherosclerotic lesions of the human aorta,” BioMed Research International, vol. 2015, Article ID 825468, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. M. A. Sazonova, “Association of mitochondrial genome mutations with lipofibrous plaques in human aortic intima,” Patologicheskaia Fiziologiia i Èksperimental'naia Terapiia, vol. 59, pp. 17–28, 2015. View at Google Scholar
  13. I. A. Sobenin, M. A. Sazonova, A. Y. Postnov, J. T. Salonen, Y. V. Bobryshev, and A. N. Orekhov, “Association of mitochondrial genetic variation with carotid atherosclerosis,” PLoS One, vol. 8, article e68070, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. I. A. Sobenin, M. A. Sazonova, A. Y. Postnov, Y. V. Bobryshev, and A. N. Orekhov, “Changes of mitochondria in atherosclerosis: possible determinant in the pathogenesis of the disease,” Atherosclerosis, vol. 227, no. 2, pp. 283–288, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. M. A. Sazonova, A. I. Postnov, A. N. Orekhov, and I. A. Sobenin, “A new method of quantitative estimation of mutant allele in mitochondrial genome,” Patologicheskaia Fiziologiia i Èksperimental'naia Terapiia, vol. 4, pp. 81–84, 2011. View at Google Scholar
  16. I. A. Sobenin, K. Y. Mitrofanov, A. V. Zhelankin et al., “Quantitative assessment of heteroplasmy of mitochondrial genome: perspectives in diagnostics and methodological pitfalls,” BioMed Research International, vol. 2014, Article ID 292017, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. M. A. Sazonova, V. V. Sinyov, A. I. Ryzhkova et al., “Role of mitochondrial genome mutations in pathogenesis of carotid atherosclerosis,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 6934394, 7 pages, 2017. View at Publisher · View at Google Scholar
  18. M. A. Sazonova, Y. Y. Budnikov, Z. B. Khazanova, A. Y. Postnov, I. A. Sobenin, and A. N. Orekhov, “PO5-115 direct quantitative assessment of mutant allele in mitochondrial genome in atherosclerotic lesion of human aorta,” Atherosclerosis Supplements, vol. 8, no. 1, pp. 45-46, 2007. View at Publisher · View at Google Scholar
  19. A. Alderborn, A. Kristofferson, and U. Hammerling, “Determination of single-nucleotide polymorphisms by real-time pyrophosphate DNA sequencing,” Genome Research, vol. 10, no. 8, pp. 1249–1258, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Goji, A. Mathews, G. Huszczynski et al., “A new pyrosequencing assay for rapid detection and genotyping of Shiga toxin, intimin and O157-specific rfbE genes of Escherichia coli,” Journal of Microbiological Methods, vol. 109, pp. 167–179, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. G. F. Zannoni, G. Improta, G. Chiarello et al., “Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma,” Virchows Archiv, vol. 465, no. 2, pp. 193–198, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Ozen, N. Kocak, S. Kelekci, I. H. Yildirim, G. Hacimuto, and O. Ozdemir, “The prevalence of Familial Mediterranean Fever common gene mutations in patients with simple febrile seizures,” European Review for Medical and Pharmacological Sciences, vol. 18, no. 5, pp. 657–660, 2014. View at Google Scholar
  23. J. A. Adams, K. M. Post, S. A. Bilbo et al., “Performance evaluation comparison of 3 commercially available PCR-based KRAS mutation testing platforms,” Applied Immunohistochemistry & Molecular Morphology, vol. 22, no. 3, pp. 231–235, 2014. View at Publisher · View at Google Scholar
  24. F. A. Amosenko, M. A. Sazonova, N. I. Kapranov, I. S. Trubnikova, and V. N. Kalinin, “Analysis of various polymorphic markers of the CFTR gene in cystic fibrosis patients and healthy donors from the Moscow region,” Russian Journal of Genetics, vol. 31, pp. 457–459, 1995. View at Google Scholar
  25. M. A. Sazonova, F. A. Amosenko, N. I. Kapranov, and V. N. Kalinin, “Molecular genetic analysis of TUB18 and TUB20 intragenic polymorphism and various mutations of the CFTR gene in the Moscow region,” Genetika, vol. 33, no. 9, pp. 1303–1307, 1997. View at Google Scholar
  26. F. A. Amosenko, I. S. Trubnikova, V. M. Zakhar'ev et al., “TUB9 polymorphism in the CFTR gene of cystic fibrosis patients, carriers, and healthy donors from the Moscow region SSCP and restriction analyses,” Genetika, vol. 33, no. 2, pp. 257–261, 1997. View at Google Scholar
  27. T. Maniatis, J. Sambrook, and E. F. Fritsch, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor The Laboratory, New York, NY, USA, 1982.
  28. July 2017, https://www.ibm.com/analytics/us/en/technology/spss.
  29. M. Sazonova, I. Andrianova, Z. Khasanova, I. Sobenin, and A. Postnov, “Quantitative mitochondrial genome mutation investigation and possible role of the somatic mutations in development of atherosclerotic lesion of human aorta,” Atherosclerosis Supplements, vol. 9, no. 1, p. 113, 2008. View at Publisher · View at Google Scholar
  30. K. Takagi, Y. Yamada, J. S. Gong, T. Sone, M. Yokota, and M. Tanaka, “Association of a 5178C→A (Leu237Met) polymorphism in the mitochondrial DNA with a low prevalence of myocardial infarction in Japanese individuals,” Atherosclerosis, vol. 175, pp. 281–286, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Mukae, S. Aoki, S. Itoh et al., “Mitochondrial 5178A/C genotype is associated with acute myocardial infarction,” Circulation Journal, vol. 67, no. 1, pp. 16–20, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. A. L. Andreu, M. G. Hanna, H. Reichmann et al., “Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA,” The New England Journal of Medicine, vol. 341, no. 14, pp. 1037–1044, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. C. L. Karadimas, L. Salviati, S. Sacconi et al., “Mitochondrial myopathy and ophthalmoplegia in a sporadic patient with the G12315A mutation in mitochondrial DNA,” Neuromuscular Disorders, vol. 12, no. 9, pp. 865–868, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Fu, R. Hartlen, T. Johns, A. Genge, G. Karpati, and E. A. Shoubridge, “A novel heteroplasmic tRNAleu(CUN) mtDNA point mutation in a sporadic patient with mitochondrial encephalomyopathy segregates rapidly in skeletal muscle and suggests an approach to therapy,” Human Molecular Genetics, vol. 5, no. 11, pp. 1835–1840, 1996. View at Publisher · View at Google Scholar · View at Scopus